These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Insights into product and process related challenges of lentiviral vector bioprocessing. Perry C; Mujahid N; Takeuchi Y; Rayat ACME Biotechnol Bioeng; 2024 Aug; 121(8):2466-2481. PubMed ID: 37526313 [TBL] [Abstract][Full Text] [Related]
3. Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing. Tran MY; Kamen AA Front Bioeng Biotechnol; 2022; 10():887716. PubMed ID: 35774066 [TBL] [Abstract][Full Text] [Related]
4. A Scalable Lentiviral Vector Production and Purification Method Using Mustang Q Chromatography and Tangential Flow Filtration. Tinch S; Szczur K; Swaney W; Reeves L; Witting SR Methods Mol Biol; 2019; 1937():135-153. PubMed ID: 30706394 [TBL] [Abstract][Full Text] [Related]
5. Process intensification for lentiviral vector manufacturing using tangential flow depth filtration. Tona RM; Shah R; Middaugh K; Steve J; Marques J; Roszell BR; Jung C Mol Ther Methods Clin Dev; 2023 Jun; 29():93-107. PubMed ID: 36994313 [TBL] [Abstract][Full Text] [Related]
6. Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Soldi M; Sergi Sergi L; Unali G; Kerzel T; Cuccovillo I; Capasso P; Annoni A; Biffi M; Rancoita PMV; Cantore A; Lombardo A; Naldini L; Squadrito ML; Kajaste-Rudnitski A Mol Ther Methods Clin Dev; 2020 Dec; 19():411-425. PubMed ID: 33294490 [TBL] [Abstract][Full Text] [Related]
7. Depth filtration for clarification of intensified lentiviral vector suspension cell culture. Mayani M; Nellimarla S; Mangalathillam R; Rao H; Patarroyo-White S; Ma J; Figueroa B Biotechnol Prog; 2024; 40(2):e3409. PubMed ID: 37985144 [TBL] [Abstract][Full Text] [Related]
8. Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media. Bauler M; Roberts JK; Wu CC; Fan B; Ferrara F; Yip BH; Diao S; Kim YI; Moore J; Zhou S; Wielgosz MM; Ryu B; Throm RE Mol Ther Methods Clin Dev; 2020 Jun; 17():58-68. PubMed ID: 31890741 [TBL] [Abstract][Full Text] [Related]
12. Clinical grade lentiviral vector purification and quality control requirements. Shi R; Jia S; Liu H; Nie H J Sep Sci; 2022 Jun; 45(12):2093-2101. PubMed ID: 35247228 [TBL] [Abstract][Full Text] [Related]
13. Scaling Up of Steric Exclusion Membrane Chromatography for Lentiviral Vector Purification. Labisch JJ; Paul R; Wiese GP; Pflanz K Membranes (Basel); 2023 Jan; 13(2):. PubMed ID: 36837652 [TBL] [Abstract][Full Text] [Related]
14. Simplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography. Kutner RH; Puthli S; Marino MP; Reiser J BMC Biotechnol; 2009 Feb; 9():10. PubMed ID: 19220915 [TBL] [Abstract][Full Text] [Related]
15. Phase I/II Manufacture of Lentiviral Vectors Under GMP in an Academic Setting. Dasgupta A; Tinch S; Szczur K; Ernst R; Shryock N; Kaylor C; Lewis K; Day E; Truong T; Swaney W Methods Mol Biol; 2020; 2086():27-60. PubMed ID: 31707666 [TBL] [Abstract][Full Text] [Related]
16. Scaleable purification process for gene therapy retroviral vectors. Rodrigues T; Carvalho A; Carmo M; Carrondo MJ; Alves PM; Cruz PE J Gene Med; 2007 Apr; 9(4):233-43. PubMed ID: 17428003 [TBL] [Abstract][Full Text] [Related]
17. Implementation of Novel Affinity Ligand for Lentiviral Vector Purification. Moreira AS; Bezemer S; Faria TQ; Detmers F; Hermans P; Sierkstra L; Coroadinha AS; Peixoto C Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834764 [TBL] [Abstract][Full Text] [Related]